Clinical Trials Browser

Phase NA × OTHER_GOV × Immune Checkpoint Inhibitors × Clear all

NCT04891900 2024-07-08

TQB2450 Plus Anlotinib Combined With Chemotherapy in the Treatment of Gastric or Gastroesophageal Junction Adenocarcinoma

Phase NA Active not recruiting

Gastrointestinal

Stomach Neoplasms

NCT05001360 2021-10-27

Study of FMT Combined With Nivolumab in Gastric Cancer

Phase NA Withdrawn

Gastrointestinal

Adenocarcinoma Of Esophagus